SCHEMBL6594035

SCHEMBL6594035

Cc1ccc(NC(=O)c2ccc3ccccc3c2)c(C(=O)Nc2ccccc2)c1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.83
NR1H4 Q96RI1 2/20 0.60
DEGS1 O15121 1/20 0.59
NPC1 O15118 6/20 0.58
RAB9A P51151 6/20 0.58
PPARG P37231 1/20 0.57
PPARD Q03181 1/20 0.57
PPARA Q07869 1/20 0.57
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
GFER P55789 1/20 0.56
PLAU P00749 2/20 0.56
RXFP1 Q9HBX9 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.55
CASP3 P42574 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
DHODH Q02127 1/20 0.55
KDM4E B2RXH2 1/20 0.54
ENPP2 Q13822 1/20 0.54
F2 P00734 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839781 0.85 NR1H4 (0.71) F10NR1H4NPC1RAB9APPARG
SCHEMBL12447826 0.82 NPC1 (0.82) F10NR1H4DEGS1NPC1RAB9A
SCHEMBL2467402 0.82 PLAU (0.78) NR1H4DEGS1NPC1RAB9AMEN1
SCHEMBL20840618 0.80 NR1H4 (0.59) F10NR1H4NPC1RAB9APPARG
SCHEMBL20848006 0.80 NPC1 (0.78) DEGS1NPC1RAB9AMEN1KMT2A
SCHEMBL6592127 0.80 F10 (0.56) F10NPC1RAB9AMEN1KMT2A
SCHEMBL13252193 0.79 RAB9A (0.76) F10NPC1RAB9AMEN1KMT2A
SCHEMBL21271819 0.78 F10 (0.56) F10NR1H4NPC1RAB9APPARG
SCHEMBL15599962 0.78 MEN1 (0.84) NPC1RAB9AMEN1KMT2ARXFP1
SCHEMBL20839737 0.77 NR1H4 (0.80) F10NR1H4NPC1RAB9APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed